Document:

manh-ex101_342.htm

Exhibit 10.1

AMENDMENT NO. 3

TO

MANHATTAN ASSOCIATES, INC.

2007 STOCK INCENTIVE PLAN

 

The Manhattan Associates, Inc. 2007 Stock Incentive Plan (the "Plan") is hereby amended (the “Amendment”) as follows:

 

1.Amendment.  Section 14.3 of the Plan is deleted in its entirety and replaced by the following:

 

“14.3 Withholding. The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company as a condition precedent for the fulfillment of any Stock Incentive, an amount sufficient to satisfy Federal, state and local taxes, domestic or foreign, to be withheld with respect to any taxable event arising as a result of this Plan and/or any action taken by a Participant with respect to a Stock Incentive. Whenever Shares are to be issued to a Participant upon exercise of an Option or a Stock Appreciation Right, or satisfaction of conditions under a Restricted Stock Unit, or grant of or substantial vesting of a Restricted Stock Award, the Company shall have the right to require the Participant to remit to the Company, as a condition of exercise of the Option or Stock Appreciation Right, or as a condition to the fulfillment of the Restricted Stock Unit, or as a condition to the grant or substantial vesting of the Restricted Stock Award, an amount in cash (or, unless the Stock Incentive Agreement provides otherwise, in Shares) sufficient to satisfy federal, state and local tax withholding obligations at the time of such exercise, satisfaction of conditions, or grant or substantial vesting. However, notwithstanding the foregoing, to the extent that a Participant is an Insider, satisfaction of tax withholding obligations by having the Company withhold Shares may only be made to the extent that such withholding of Shares (1) has met the requirements of an exemption under Rule 16b-3 promulgated under the Exchange Act, or (2) is a subsequent transaction the terms of which were provided for in a transaction initially meeting the requirements of an exemption under Rule 16b-3 promulgated under the Exchange Act. Unless the Stock Incentive Agreement provides otherwise, the withholding of shares to satisfy federal, state and local tax withholding obligations shall be a subsequent transaction approved by the original grant of a Stock Incentive. Notwithstanding the foregoing, the payment of tax withholding obligations may not be made by a retention of Shares by the Company unless the Fair Market Value of the Shares retained does not exceed the maximum amount permitted for the Company to treat the Stock Incentive as an equity award for accounting purposes and to comply with applicable tax withholding rules.” 

 

2.Effective Date. The effective date of this Amendment is January 26, 2017.

 

3.Miscellaneous.

 

(a)Capitalized terms not otherwise defined herein shall have the meanings given them in the Plan.

 

(b)The headings of this Amendment have been inserted for convenience of reference only and if there is a conflict, the text of this Amendment, rather than the headings, will control.

 

(c)Except as specifically amended hereby, the Plan shall remain in full force and effect.MICROBOT
MEDICAL LTD.

 

2015
STOCK OPTION PLAN

 

	1.	PURPOSE
	 	 
	 	The
    purpose of this 2015 Stock Option Plan is to secure for Microbot Medical Ltd. and its shareholders the benefits arising from
    ownership of share capital by employees, officers, directors and consultants of the Company and its Affiliates (as defined
    below), who are expected to contribute to the Company’s future growth and success.
	 	 
	2.	DEFINITIONS
	 	 
	2.1.	DEFINED
    TERMS
	 	 
	1.	Initially
    capitalized terms, as used in this Plan, shall have the meaning ascribed thereto as set forth below:

 

	“Administrator”

         

         
	means,
    the Board of Directors of the Company, or a committee to which the Board of Directors shall have delegated power to act on
    its behalf with respect to the Plan. Subject to the Articles of Association of the Company, as may be amended from time to
    time, the Administrator, if it is a committee, shall consist of such number of members (but not less than two (2)) as may
    be determined by the Board and subject to the requirements of the Law.
	 	 
	“Affiliate(s)”	Means,
    a present or future company that either (i) Controls Microbot Medical Ltd. or is Controlled by Microbot Medical Ltd.; or (ii)
    is Controlled by the same person or entity that Controls Microbot Medical Ltd.
	 	 
	“Allocate”
    or “Allocated”	with
    respect to Options, means the allocation of Options by the Company to the Trustee on behalf of a Participant.
	 	 
	“Board”	means,
    the Board of Directors of the Company.
	 	 
	“Cause”	means,
    when used in connection with the termination of a Participant’s employment with, or service to the Company or an Affiliate,
    as a result of a basis for termination, including, but not limited to: dishonesty toward the Company or its Affiliate, insubordination,
    substantial malfeasance or nonfeasance of duty, unauthorized disclosure of confidential information, and conduct substantially
    prejudicial to the business of the Company or Affiliate; or, any substantial breach by the Participant of (i) his or her employment
    or service agreement or (ii) any other obligations toward Company or Affiliate.

 

CONFIDENTIAL

 

    	 	 1	  

    	 	 	 

    

 

	 “Code”	means,
    the United States Internal Revenue Code of 1986, as amended, and any applicable regulations promulgated thereunder.
	 	 
	“Commencement
    Date”	means,
    the date of commencement of the vesting schedule with respect to a Grant of Options.
	 	 
	“Company”	means,
    Microbot Medical Ltd., a company incorporated under the laws of the State of Israel.
	 	 
	“Consultant”	means,
    any person (other than an Employee or a Director) who is engaged by the Company, a Subsidiary or an Affiliate to render consulting
    or advisory services to the Company or such Subsidiary or Affiliate.
	 	 
	“Continuous
    Service”	means,
    with respect to a Non-Israeli Participant - that the provision of services to the Company or a Subsidiary or Affiliate in
    any capacity of Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance
    of an effective termination as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the
    actual cessation of providing services to the Company or a Subsidiary or Affiliate notwithstanding any required notice period
    that must be fulfilled before a termination as an Employee, Director or Consultant can be effective under applicable labor
    laws. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers
    among the Company, any Subsidiary or Affiliate, or any successor, in any capacity of Employee, Director or Consultant, or
    (iii) any change in status as long as the individual remains in the service of the Company or a Subsidiary or Affiliate in
    any capacity of Employee, Director or Consultant (except as otherwise provided in the Award agreement). An approved leave
    of absence shall include sick leave, military leave, or any other authorized personal leave. For purposes of each Incentive
    Stock Option granted under the Plan, if such leave exceeds ninety (90) days, and reemployment upon expiration of such leave
    is not guaranteed by statute or contract, then the Incentive Stock Option shall be treated as a Non-Qualified Option on the
    day three (3) months and one (1) day following the expiration of such ninety (90) day period.

 

CONFIDENTIAL

 

    	 	 2	  

    	 	 	 

    

 

	“Control”
    or “Controlled”	shall
    have the meaning ascribed thereto in Section 102.
	 	 
	“Director”	With
    respect to Israeli Participant - as defined in Israeli Companies Law 5759 - 1999.
	 	 
	 	With
    respect to Non-Israeli Participants - means, each member of the Board of Directors of the Company who is not an Employee,
    who does not receive compensation from the Company or any Subsidiary in any capacity other than as a Director and whose membership
    on the Board is not attributable to any contract between the Company and such Director or any other entity with which such
    Director is affiliated.
	 	 
	“Disability”	means
    total and permanent physical or mental impairment or sickness of a Participant, making it impossible for the Participant to
    continue such Participant’s employment with or service to the Company or Affiliate.
	 	 
	“Employee”	With
    respect to Israeli Participants - as defined under Section 102 (including, officers of the Company that are not formally considered
    employees of the Company, but are entitled to participate in such a plan under Section 102). With respect to Non-Israeli Participants
    - means, an officer or other employee of the Company, a Subsidiary or an Affiliate, including a director who is such an employee.
	 	 
	“Exercise
    Price”	means,
    the price determined by the Administrator in accordance with Section 7.1 below which is to be paid to the Company in order
    to exercise a Granted Option and convert such Option into an Underlying Share.
	 	 
	“Grant
    Letter”	means,
    a letter from the Company or Affiliate to a Participant in which the Participant is notified of the decision to Grant to the
    Participant Options according to the terms of the Plan. The Grant Letter shall specify (i) the Tax Track that the Company
    chose according to Section 12 of the Plan (if applicable); (ii) the Exercise Price; (iii) the number of Options Granted to
    the Participant; and (iv) the date of Grant.
	 	 
	“Grant
    of Options”	with
    respect to Options, means the grant of Options by the Company to a Participant pursuant to a Grant Letter.

 

CONFIDENTIAL

 

    	 	 3	  

    	 	 	 

    

 

	“Holding
    Period”	means,
    with regard to Options Granted under Section 102, the period in which the Allocated Options granted to a Participant or, upon
    exercise thereof the Underlying Shares, are to be held by the Trustee on behalf of the Participant, in accordance with Section
    102, and pursuant to the Tax Track which the Company selects.
	 	 
	“Incentive
    Stock Options”	means,
    Options Granted to Non-Israeli Participants, in accordance with the provisions of section 422 of the Code and designated as
    an Incentive Stock Option.
	 	 
	“IPO”	means,
    the initial public offering of shares of the Company and the listing of such shares for trading on any recognized stock exchange
    or over-the-counter or computerized securities trading system.
	 	 
	“Israeli
    Participant”	means,
an Israeli resident who is an employee, officer or director of the Company or any Affiliate (provided that such person does not
Control the Company as such term is defined in the Tax Ordinance), on behalf of whom an Option is Granted pursuant to Section
102.

	 	 
	“Law”	means,
    the laws of the State of Israel as are in effect from time to time and any US law applicable to Options Granted to Non-Israeli
    Participants.
	 	 
	“Notice
    of Exercise”	shall
    have the meaning set forth in Section 7.3 below.
	 	 
	“Option”	means,
    an option to purchase one Share of the Company.
	 	 
	“Non-Israeli
    Participant”	means,
    a non-Israeli resident, on behalf of whom an Option is Granted pursuant to the Code.
	 	 
	“Non-Qualified
    Israeli Participant”	means,
an Israeli resident who is not qualified to receive Options under the provisions of Section 102, on behalf of whom an Option is
Granted pursuant to Section 3i.

	 	 
	“Participant”	means,
    an Israeli Participant, or a Non-Qualified Israeli Participant, or a Non-Israeli Participant, or a Consultant.
	 	 
	“Non-Qualified
    Option”	means,
    an Option not intended to be an Incentive Stock Option, and designated as a Non-Qualified Option.
	 	 
	“Plan”
    or “Option Plan	means,
        this Stock Option Plan, as may be amended from time to time.

        

 

CONFIDENTIAL

 

    	 	 4	  

    	 	 	 

    

 

	“Retirement”	means,
    the termination of a Participant’s employment as a result of his or her reaching the earlier of (i) the age of retirement
    as defined by Law; or (ii) the age of retirement specified in the Participant’s employment agreement.
	 	 
	“Section
    102”	means,
    Section 102 of Israeli Tax Ordinance, as may be amended from time to time.
	 	 
	“Section
    102 Rules”	means,
    the Income Tax Rules (Tax Relief for Issuance of Shares to Employees), 2003, as may be amended from time to time.
	 	 
	“Section
    3(i)”	means,
    section 3(i) of the Israeli Tax Ordinance and any applicable rules thereto, as may be amended from time to time.
	 	 
	“Share(s)”	means,
    an ordinary share of the Company, having a par value of NIS 1.
	 	 
	“Subsidiary”	means
    a subsidiary of the Company as defined in Section 424(f) of the Code.
	 	 
	“Tax
    Ordinance”	means,
    the Israeli Income Tax Ordinance [New Version], 1961, as amended, and any regulations, rules, orders or procedures promulgated
    thereunder.
	 	 
	“Capital
    Gains Tax Track Through a Trustee”	means,
    the “Capital Gains Track Through a Trustee” as provided for in Section 102 of the Tax Ordinance.
	 	 
	“Tax
    Provision”	means,
    with respect to the Grant of Options, the provisions of the Capital Gains Tax Track of Section 102, or the provisions of 3i,
    or the provisions of the Code.
	 	 
	“Ten
    Percent Shareholder”	means,
    a person who on any given date owns, either directly or indirectly (taking into account the attribution rules contained in
    Section 424(d) of the Code), stock possessing more than 10% of the total combined voting power of all classes of stock of
    the Company or a Subsidiary.
	 	 
	“Term
    of the Options”	means,
    with respect to Granted but unexercised Options, the time period set forth in Section 9 below.
	 	 
	“Trustee”	means,
    a Trustee appointed by the Company to hold in trust, Allocated Options and the Underlying Shares issued upon exercise of such
    Options, on behalf of Israeli Participants.
	 	 
	“Underlying
    Shares”	means,
    Shares issued or issuable upon exercise of Granted Options all in accordance with the Plan.

 

 CONFIDENTIAL

 

    	 	 5	  

    	 	 	 

    

 

	2.2.	GENERAL
	 	 
	 	Without
    derogating from the meanings ascribed to the capitalized terms above, all singular references in this Plan shall include the
    plural and vice versa, and reference to one gender shall include the other, unless otherwise required by the context.
	 	 
	3.	SHARES
    AVAILABLE FOR OPTIONS
	 	 
	 	The
    total number of Underlying Shares reserved for issuance under the Plan and any modification thereof, shall be as resolved
    by the Company’s Board of Directors. Such number of Shares shall be subject to adjustments as required for the implementation
    of the provisions of the Plan, in accordance with Section 4 below.
	 	 
	 	In
    the event that the right to exercise Options Granted under the Plan expires or otherwise terminates in accordance with the
    provisions of the Plan, such Options shall become available for future Grants and Allocations under the Plan.
	 	 
	4.	ADJUSTMENTS
	 	 
	4.1.	ADJUSTMENT
    OF OPTIONS - BONUS SHARES
	 	 
	 	Should
    the Company distribute bonus shares to its shareholders (“Bonus Shares”), then the number of Underlying Shares
    issued for Options exercised after such distribution, shall be increased by the number of Bonus Shares issued per Share. The
    exercise price of each Option will not change as a result of such adjustment. All provisions referring to Underlying Shares
    shall also apply with respect to the Bonus Shares distributed by such adjustments.
	 	 
	4.2.	CHANGE
    OF COMPANY’S CAPITAL
	 	 
	 	In
    an event such as a stock split or a reverse stock split or any such other change in the corporate structure of the Company
    effecting its Share capital, then the Board of Directors of the Company shall make any changes or adjustments with respect
    to the number and class of the Underlying Shares and/or the Exercise Price of each Option, in order to prevent diminution
    or enlargement of the benefits or potential benefits intended to be made available under the Plan.
	 	 
	4.3.	FRACTION
    OF SHARES
	 	 
	 	In
    any event that the Company will be required to issue to a Participant fraction of Shares pursuant to this Section 4, the Company
    will not issue fraction of Shares and the number of Shares shall be rounded down to the closest number of Shares.

 

CONFIDENTIAL

 

    	 	 6	  

    	 	 	 

    

 

	5.	ADMINISTRATION
    OF THE PLAN
	 	 
	5.1.	POWER
	 	 
	 	Subject
    to the Law, the Articles of Association of the Company, and any resolution to the contrary by the Company’s Board of
    Directors, the Administrator is authorized, in its sole and absolute discretion, to exercise all powers and authorities either
    specifically granted to it under the Plan or necessary or advisable in the administration of the Plan; including, without
    limitation,
	 	 
	 	to
    determine:

 

	 	(i)	the
    Participants in the Plan, and the number of Options to be Granted for each Participant’s benefit (subject to the approval
    of the Board of Directors if such approval is required by Law);
	 	 	 
	 	(ii)	the
    time or times at which Options shall be Granted;
	 	 	 
	 	(iii)	the
    Exercise Price for any Granted Option;
	 	 	 
	 	(iv)	whether,
    to what extent, and under what circumstances an Option may be settled, canceled, forfeited, exchanged, or surrendered;
	 	 	 
	 	(v)	any
    terms and conditions in addition to those specified in the Plan under which an Option may be Granted; and
	 	 	 
	 	(vi)	any
    measures, and to take actions, as deemed necessary or advisable for the administration and implementation of the Plan.
	 	 	 
	 	(vii)	subject
    to Section 7, to accelerate the date on which any Option allocated to a certain Participant under the Plan becomes exercisable;
	 	 	 
	 	(viii)	to
    grant Option to Participants who are foreign nationals or employed outside Israel and/or the United States, on such terms
    and conditions different from those specified in the Plan, as may, in the discretion of the Administrator, be necessary or
    desirable to further the purpose of the Plan.
	 	 	 
	 	(ix)	to
    exercise all powers and authorities granted to him under the Plan; and
	 	 	 
	 	(x)	to
    the extent required - to interpret and to determine how to implement the provisions of the Plan;

 

	5.2.	LIMITATIONS
	 	 
	 	Notwithstanding
    the provisions of Section 5.1 above, no interpretations, determinations or actions of the Administrator shall contradict the
    provisions of applicable Law, and no waiver or amendment with respect to the Plan shall have a material adverse affect on
    any Participant’s rights in connection with any Granted Option under the Plan without receiving the consent of such
    Participant.

 

CONFIDENTIAL

 

    	 	 7	  

    	 	 	 

    

 

	6.	GRANT
    AND ALLOCATION OF OPTIONS
	 	 
	6.1.	CONDITIONS
    FOR ALLOCATION OF OPTIONS
	 	 
	 	Options
    may be Allocated at any time after:

 

	 	(A)	the
    Plan has been approved by the necessary corporate bodies of the Company; and
	 	 	 
	 	(B)	30
    days after a request for approval of the Plan has been submitted to the Israeli Income Tax Authorities pursuant to the requirements
    of the Tax Ordinance; and
	 	 	 
	 	(C)	all
    other approvals, consents or requirements necessary by Law have been received or met.

 

	6.2.	ELIGIBILITY
    FOR OPTIONS
	 	 
	 	The
    Administrator may grant Options to any Employee, officer, Director, or Consultant of the Company and its Affiliates, provided,
    however, that Incentive Stock Options only may be granted to Employees.
	 	 
	6.3.	DATE
    OF GRANT OR ALLOCATION

 

	 	(a)	The
    date on which Options shall be deemed Granted under the Plan shall be the date on which the Company shall notify the Participant
    in a Grant Letter that such Options have been Granted to the Participant or the date specified as the date of grant in the
    Grant Letter, if specified (“Date of Grant”).
	 	 	 
	 	(b)	With
    respect to Israeli Participants - the date on which Options shall be deemed Allocated under the Plan shall be the date on
    which the Company shall notify the Trustee that such Options have been Allocated in the name of the Trustee on behalf of a
    Participant; and with respect to Non-Israeli Participants - the date on which the Company shall notify such Participant that
    Options have been allocated in his name, or any other date specified in the Grant Letter as the date of Allocation, if specified
    (“Date of Allocation”).

 

	6.4.	GRANT
    LETTERS
	 	 
	 	Any
    grant of Options to a Participant shall be made in a form of a Grant Letter and shall include a copy of the Plan. The receipt
    by a Participant of such Grant Letter shall be deemed a consent by such Participant that the Option is subject to all the
    terms and conditions of the Grant Letter and the Plan.
	 	 
	 	The
    Administrator may include in the Grant Letters any provision, which it deems necessary, in order to adjust the terms of the
    Grant of Options to applicable laws of the jurisdiction in which Participants reside.

 

CONFIDENTIAL

 

    	 	 8	  

    	 	 	 

    

 

	7.	EXERCISE
    OF OPTIONS
	 	 
	7.1.	EXERCISE
    PRICE
	 	 
	 	The
    Exercise Price per Underlying Share deliverable upon the exercise of an Option shall be determined by the Board or by a committee
    of the Board to which the Board delegated such power, in accordance with detailed parameters adopted by the Board. The Exercise
    Price shall be set forth in the Grant Letter.
	 	 
	 	Notwithstanding
    the above, the exercise price of Incentive Stock Options Granted to a Non-Israeli Participant shall not be less than 100%
    of the Fair Market Value of the Share as defined below, unless expressly required otherwise by the law applicable to a Non-Israeli
    Participant. If an Incentive Stock Option is Granted to a Non-Israeli Participant owning more than ten percent of the shares
    of the Company or of a Subsidiary, or possessing at the time of the Grant more than ten percent of the total combined voting
    power of all classes of shares of the Company (or of its Subsidiary), then the Exercise Price shall be no less then 110% of
    the Fair Market Value of the Share at the time of Grant.
	 	 
	 	Notwithstanding
    the foregoing, Incentive Stock Options may be Granted with an Exercise Price other than as required above, pursuant to a Merger
    Transaction and in accordance with Section 424 of the Code.
	 	 
	 	“Fair
    Market Value” means, as of any date, the value of the Shares determined as follows:

 

	 	(1)	if
    the Shares are listed on any established stock exchange or a national market system, including without limitation the NASDAQ
    National Market System, or the NASDAQ SmallCap Market of the NASDAQ Stock Market, the Fair Market Value shall be the closing
    sales price for such shares (or the closing bid, if no sales were reported), as quoted on such exchange or system for the
    last market trading day prior to time of determination, as reported in the Wall Street Journal, or according to any other
    source the Administrator deems reliable;
	 	 	 
	 	(2)	if
    the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value
    shall be the average between the high bid and low asked prices for the Shares on the last market trading day prior to the
    day of determination; or
	 	 	 
	 	(3)	in
    the absence of an established market for the Shares, the Fair Market Value thereof shall be determined in good faith by the
    Administrator.

 

 CONFIDENTIAL

 

    	 	 9	  

    	 	 	 

    

 

	 	Notwithstanding
    the aforesaid, if the aggregate Fair Market Value of the Incentive Stock Options that are exercisable for the first time by
    the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds $100,000, such
    Options shall be treated as Non-Qualified Stock Options.
	 	 
	 	For
    the purpose of this Section a “Merger Transaction” shall be (i) a sale of all or substantially all of the assets
    of the Company; or (ii) a sale (including an exchange) of all or substantially all of the shares of the capital stock of the
    Company; or (iii) a merger, consolidation or like transaction of the Company with or into another corporation.
	 	 
	7.2.	VESTING
    SCHEDULE
	 	 
	 	Unless
    otherwise determined by the Administrator, all Options Granted on a certain date shall, subject to continued employment with
    or service to the Company or Affiliate by the Participant, become vested and exercisable in accordance with the following
    vesting schedule:

 

	 	(A)	25%
    of the Options shall be exercisable on the first anniversary of the Commencement Date, and shall remain exercisable until
    the end of the Term of the Options.
	 	 	 
	 	(B)	Thereafter,
    all Options shall vest over a period of 36 months, on a calendar quarterly basis.
	 	 	 
	 	(C)	In
    accordance with the above, all Options Granted to a Participant shall be fully vested and exercisable on the fourth anniversary
    of the Commencement Date and shall remain exercisable until the end of the Term of the Options, provided however that should
    determined by the Administrator that part of the Options are vested upon consummation of certain milestones, such party shall
    only be deemed vested upon the confirmation in writing by Administrator (at it sole discretion) that such milestone was consummated.
	 	 	 
	 	(D)	The
    Administrator may, at its discretion, accelerate the vesting of all or part of the Options, for part or all of the Participants,
    all at its sole discretion, including, but not limited to, in connection with the initial public offering of Company’s
    Shares and/or Company’s sale of all or substantial part of its Shares and/or assets.

 

	7.3.	MANNER
    OF EXERCISE
	 	 
	 	An
    Option may be exercised by and upon the fulfillment of the following:

 

CONFIDENTIAL

 

    	 	 10	  

    	 	 	 

    

 

	 	(A)	Notice
    of Exercise
	 	 	 
	 	 	The
    signing by the Participant, and delivery to both the Company (at its principal office) and the Trustee (if the Options are
    held by a Trustee), of an exercise notice form as prescribed by the Administrator, including but not limited to: (i) the identity
    of the Participant, (ii) the number of Options to be exercised, and (iii) the Exercise Price to be paid (the “Notice
    of Exercise”).
	 	 	 
	 	(B)	Exercise
    Price
	 	 	 
	 	 	The
    payment by the Participant to the Company, in such manner as shall be determined by the Administrator, of the Exercise Price
    with respect to all the Options exercised, as set forth in the Notice of Exercise.
	 	 	 
	 	(C)	Allocation
    of Shares
	 	 	 
	 	 	Upon
    the delivery of a duly signed Notice of Exercise and the payment to the Company of the Exercise Price with respect to all
    the Options specified therein, the Company shall issue the Underlying Shares to the Trustee (according to the applicable Holding
    Period) or to the Participant, as the case may be.
	 	 	 
	 	(D)	Expenses
	 	 	 
	 	 	All
    costs and expenses including broker fees and bank commissions, derived from the exercise of Options or Underlying Shares,
    shall be borne solely on the Participant.

 

	8.	WAIVER
    OF OPTION RIGHTS
	 	 
	 	At
    any time prior to the expiration of any Granted (but unexercised) Option, a Participant may waive his rights to such Option
    by a written notice to the Company’s principal office. Such notice shall specify the number of Options Granted, which
    the Participant waives, and shall be signed by the Participant. Upon receipt by the Company of a notice of waiver of such
    rights, the rights of the Participant with respect to such Options shall expire and the Options shall become available for
    future Grants and Allocations under the Plan.
	 	 
	9.	TERM
    OF THE OPTIONS
	 	 
	 	Unless
    earlier terminated pursuant to the provisions of this Plan, all Granted but unexercised Options shall expire and cease to
    be exercisable at 5:00 p.m. Israel time on the 10th anniversary of the Commencement Date of such Options.

 

CONFIDENTIAL

 

    	 	 11	  

    	 	 	 

    

 

	10.	EXPIRATION
    OF THE OPTIONS
	 	 
	10.1.	Exercised
    Options shall expire automatically upon the issuance of the Underlying Shares.
	 	 
	10.2.	A
    Participant’s right to exercise an Option shall expire at the end of the Term of such Option.
	 	 
	10.3.	If
    the right of a Participant to exercise an Option expired, the Option shall not grant any rights to such Participant.
	 	 
	11.	TERMINATION
    OF EMPLOYMENT
	 	 
	11.1.	TERMINATION
    OF EMPLOYMENT
	 	 
	 	If
    an Israeli Participant ceases to be an employee, director, officer or Consultant of the Company or Affiliate for any reason,
    and/or if the Continuous Service of a Non-Israeli Participant is terminated for any reason (“Termination of Employment”)
    other than death, Retirement, Disability or Cause, then any vested but unexercised Options on the date of Termination of Employment
    (as shall be determined by the Company or Affiliate, in its sole discretion), Allocated on such Participant’s behalf
    (“Exercisable Options”) may be exercised, if not previously expired, not later than the earlier of (i)
    90 days after Termination of Employment (which period may be extended by the Administrator); or (ii) the Term of the Options.
	 	 
	 	The
    right of such Participant to exercise all other Options shall expire upon the date of Termination of Employment.
	 	 
	11.2.	TERMINATION
    FOR CAUSE
	 	 
	 	In
    the event of Termination of Employment of a Participant for Cause, the Participant’s right to exercise any unexercised
    Options, Granted to such Participant, whether vested or not on the date of Termination of Employment, shall cease as of such
    date of Termination of Employment, and the Options shall thereupon expire.
	 	 
	 	If
    subsequent to the Participant’s Termination of Employment, but prior to the exercise of Options Granted to such Participant,
    the Administrator determines that either prior or subsequent to the Participant’s Termination of Employment, the Participant
    engaged in conduct which would constitute Cause, then the Participant’s right to exercise the Options Granted to such
    Participant shall immediately cease upon such determination and the Options shall thereupon expire.
	 	 
	 	The
    determination by the Administrator as to the occurrence of Cause shall be final and conclusive for all purposes of this Plan.
	 	 
	11.3.	TERMINATION
    BY REASON OF DEATH, RETIREMENT, OR DISABILITY
	 	 
	 	In
    the event of Termination of Employment of a Participant by reason of death, Retirement, or Disability, any vested but unexercised
    Options shall be exercisable in the case of death, by his or her estate, personal representative or beneficiary, or in the
    case of Retirement or Disability, by the Participant or his or her personal representative (as the case may be), until the
    end of the Term of the Options.

 

CONFIDENTIAL

 

    	 	 12	  

    	 	 	 

    

 

	 	The
    right of the Participant to exercise all other Options shall expire upon the date of Termination of Employment or upon termination
    of Continuous Service, as applicable.
	 	 
	11.4.	EXCEPTIONS
	 	 
	 	In
    special circumstances, pertaining to the Termination of Employment of a certain Participant, the Administrator may in its
    discretion decide to extend any of the periods stated above in Sections 10.1-10.3, subject to Section 9 above.
	 	 
	11.5.	TRANSFER
    OF EMPLOYMENT OR SERVICE
	 	 
	 	Subject
    to the receipt of appropriate approvals from the Israeli Tax Authorities, if applicable, a Participant’s right to Options
    or the exercise thereof that were Granted to him or her under this Plan, shall not be terminated or expired solely as a result
    of the fact that the Participant’s employment or service as an employee, officer, director or Consultant changes from
    the Company to an Affiliate or vice versa. Any and all tax consequence of such a transfer, if any, shall be solely borne by
    the Participant.
	 	 
	12.	OPTIONS
    AND TAX PROVISIONS
	 	 
	 	All
    Options under this Plan shall be Granted in accordance with one of the Tax Provisions as follows:
	 	 
	●	The
    Company shall Grant Options to Israeli Participants in accordance with the provisions of Section 102 and the Rules related
    to the Capital Gains Tax Track. Options that are Granted under Section 102 can only be granted to Israeli Participants, which
    are Employees and/or Directors of the Company and its Affiliates.
	 	 
	●	The
    Company shall Grant Options to Non-Qualified Israeli Participants in accordance with the provisions of Section 3(i).
	 	 
	●	The
    Company may Grant Incentive Stock Options or Non-Qualified Options to Non- Israeli Participants under the Provisions of the
    Section 422 of the Code. Options granted to Non-Israeli Participants which are Directors and/or Consultants of the Company
    shall be Non-Qualified Options.
	 	 
	12.1.	TAX
    PROVISION SELECTION
	 	 
	 	The
    Company shall elect under which Tax Provision each Option is Granted in accordance with any applicable Law and its sole discretion
    - i.e. the Company shall elect, in accordance with applicable Laws, if to Grant Options to Participants under the Capital
    Gains Tax Track, or under the provisions of 3i, or under the provisions of the Code. The Company shall notify each Participant
    in the Grant Letter, under which Tax Provision the Options are Granted. If the Company does not specify at grant the Tax Provision
    under which an Option granted to a Non-Israeli Participant is granted, such Option shall be deemed to be a Non-Qualified Option.

 

CONFIDENTIAL

 

    	 	 13	  

    	 	 	 

    

 

	12.2.	SECTION
    102 TRUSTEE TAX TRACKS
	 	 
	 	With
    respect to Options granted under the Capital Gains Tax Track, in accordance with the requirements of Section 102, the Company
    shall appoint a Trustee who will hold in trust on behalf of each Israeli Participant the Allocated Options and the Underlying
    Shares issued upon exercise of such Options in trust on behalf of each Israeli Participant.
	 	 
	 	The
    Holding Period for such Options will be as follows:

 

	 	(1)	24
    months from the date of Allocation; or
	 	 	 
	 	(2)	such
    period as may be determined in any amendment of Section 102.

 

	 	Subject
    to Section 102 and the Rules, Israeli Participants shall not be able to receive from the Trustee, nor shall they be able to
    sell or dispose of Underlying Shares before the end of the applicable Holding Period. If a Participant sells or removes the
    Underlying Shares form the Trustee before the end of the applicable Holding Period (“Breach”), the Participant
    shall pay all applicable taxes imposed on such Breach by Section 7 of the Rules.
	 	 
	 	In
    the event of a distribution of rights, including an issuance of bonus shares, in connection with Options originally Allocated
    (the “Additional Rights”), subject to the terms of this Plan hereinabove, all such Additional Rights shall
    be Allocated and/or issued to the Trustee for the benefit of Israeli Participants, and shall be held by the Trustee for the
    remainder of the Holding Period applicable to the Options originally Allocated. Such Additional Rights shall be treated in
    accordance with the provisions of the applicable Tax Track.
	 	 
	12.3.	CONCURRENT
    CONDITIONS
	 	 
	 	The
    Holding Period and vesting period may run concurrently, but neither is a substitute for the other, and each are independent
    terms and conditions for Options Granted.
	 	 
	12.4.	TRUST
    AGREEMENT
	 	 
	 	The
    terms and conditions applicable to the trust on behalf of Israeli Participants relating to the Capital Gains Tax Track shall
    be set forth in an agreement signed by the Company and the Trustee (the “Trust Agreement”).
	 	 
	12.5.	INCENTIVE
    STOCK OPTIONS
	 	 
	 	If
    the Option Granted is an Incentive Stock Option, and if the Non-Israeli Participant sells or otherwise disposes of any of
    the Underlying Shares on or before the later of (i) the end of two years following the Date of Grant; and (ii) the end of
    one year following the transfer of such Underlying Shares to the Non-Israeli Participant upon exercise of the Option (“the
    Code Holding Period”), then the Non-Israeli Participant shall immediately notify the Company of such disposition of
    the Underlying Shares.

 

CONFIDENTIAL

 

    	 	 14	  

    	 	 	 

    

 

	 	Any
    disposition of the Underlying Shares before the end of the Code Holding Period, may impose income tax withholding liabilities
    on the Company or Subsidiary as the case may be, and may impose other tax liabilities on the compensation income recognized
    from the such disposition.
	 	 
	13.	TERM
    OF SHARES HELD IN TRUST
	 	 
	 	No
    Underlying Shares or Additional Rights issued by the Company to the Trustee, shall be held by the Trustee on behalf of the
    Israeli Participant for a period longer than ten (10) years after the end of the Term of the Options. The Administrator shall
    instruct the Trustee as to the transfer of these Shares.
	 	 
	14.	RIGHTS
    AS A SHAREHOLDER
	 	 
	 	Unless
    otherwise specified in the Plan, a Participant shall not have any rights as a shareholder with respect to Shares issued under
    this Plan, until such time as the Shares shall be registered in the name of the Participant in the Company’s register
    of shareholders or if applicable, in the Trustee’s name for the benefit of the Participant.
	 	 
	 	The
    Participants shall be entitled to receive any cash dividend paid to the shareholders of the Company with respect to Shares
    issued to them under this Plan (but only after and subject to the issuance of such Shares under their name). Payments of such
    dividend to the Participants shall be subject to any required tax being withheld or otherwise deducted by the Trustee or the
    Company, as agreed between the Company and the Trustee.
	 	 
	15.	NO
    SPECIAL EMPLOYMENT RIGHTS
	 	 
	 	Nothing
    contained in this Plan shall confer upon any Participant any right with respect to the continuation of employment by or service
    to the Company or Affiliate or to interfere in any way with the right of the Company or Affiliate, to terminate such employment
    or service or to increase or decrease the compensation of the Israeli Participant.
	 	 
	 	No
    Participant shall have any claim or demand with respect to any of the Options, except according to the specific terms of the
    Grant Letter provided to him or her by the Company.
	 	 
	16.	RESTRICTIONS
    ON SALE OF OPTIONS AND SHARES
	 	 
	16.1.	OPTIONS
	 	 
	 	Options
    may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent.

 

CONFIDENTIAL

 

    	 	 15	  

    	 	 	 

    

 

	16.2.	SHARES
	 	 
	 	Shares
    issued under this Plan shall be subject to all limitation imposed by the Company’s Articles of Association.
	 	 
	 	Without
    derogating the aforesaid, until the consummation of an IPO, the Underlying Shares shall be subject to a Right of First Refusal,
    as follows:

 

	 	(i)	Should
    a Participant wish to sell the Underlying Shares, in whole or in part (the “Offered Shares”), such Participant
    shall first offer these shares to all the shareholders of the Company who hold more than 5% of the Company’s shares
    on a fully diluted basis and to those Participants who would hold more than 5% of the Company’s shares on a fully diluted
    basis, if they exercise the full amount of their Granted Options (whether vested or not) (the “Offeror”
    and the “Offerees”, respectively). Such an offer shall be in writing and shall include details as determined
    by the Company from time to time (the “Offer”). In addition, the Offer shall be simultaneously delivered
    to the registered office of the Company.
	 	 	 
	 	(ii)	Each
    of the Offerees shall be entitled to notify the Offeror, within 30 days as of the receipt of the Offer, of his interest or
    lack of interest to accept the Offer and to purchase all or any part of the Offered Shares on the terms of the Offer (“Notice
    of Acceptance”).
	 	 	 
	 	(iii)	Should
    the number of shares that the all or any of the Offerees are interested to purchase exceed the number of the Offered Shares,
    the Offerees who have provide the Company a Notice of Acceptance shall receive their portion of the Offered Shares, according
    to their holdings in the Company (pro-rata) on the date of the acceptance of the Offer.
	 	 	 
	 	(iv)	Should
    the total number of shares that all the Offerees are interested in purchasing be lower than the number of the Offered Shares,
    the Offeror shall issue a written notice to this effect to all the Offerees who have sent timely Notice of Acceptance. In
    his notice, the Offeror shall specify the number of shares with respect to which no Notice of Acceptance has been received
    (hereinafter: the “Re-Offered Shares”). Such Offerees shall be entitled to notify the Offeror within three
    (3) business days of the receipt of such notice regarding their interest to purchase an additional number of shares (hereinafter:
    the “Additional Notice of Acceptance”).
	 	 	 
	 	(v)	Should
    the number of shares with respect to which the aforesaid Offerees have announced their interest in the purchase thereof by
    means of an Additional Notice of Acceptance exceed the number of the Re-Offered Shares, the Offerees that have submitted an
    Additional Notice of Acceptance shall receive their portion of the Re-Offered, according to their holdings in the Company
    (pro-rata) on the date of the acceptance of the Offer.

 

CONFIDENTIAL

 

    	 	 16	  

    	 	 	 

    

 

	 	(vi)	Should
    a Notice of Acceptance not be provided to the Offeror within the 30-day period mentioned above, or should the Offerees notify
    that they do not accept the Offer, or should the total number of shares that all the Offerees are interested in purchasing,
    even after the re-offering of the shares, be lower than the number of the Offered Shares, the Offeror shall not be obligated
    to transfer the Offered Shares to the Offerees and he will be entitled to sell the Offered Shares to such purchaser (the “Purchaser”)
    on terms that are identical or better that the terms of the Offer, provided that if the Offered Shares are sold to the Purchaser
    within 60 days as of the end of the 30-day period for the issuance of a Notice of Acceptance or of the date on which the notices
    of non-acceptance are received or after the three business days period during which time the Offerees are entitled to issue
    an Additional Notice of Acceptance, as stated in Section (iv) above, as the case may be.
	 	 	 
	 	(vii)	The
    provisions of Sections (i) - (vi) above shall only be in effect until the consummation of an IPO by the Company.

 

	16.3.	ACCELERATION
    PROVISION
	 	 
	 	The
    Administrator, in its sole discretion, may resolve, with respect to a specific Participant (or certain specific Participants),
    that all or some of the unvested Options of Such Participant/s will be accelerated.
	 	 
	16.4.	LOCK
    UP
	 	 
	 	Notwithstanding
    the Holding Period, following the Company’s IPO, at the request of the underwriters or if required under applicable
    law and/or by any governmental authority, the Administrator may determine that the Underlying Shares issued pursuant to the
    exercise of Options may be subject to a lock-up period of up to 180 days, or such other period of time as may be recommended
    by the Company’s Board of Directors, during which time Participants shall not be allowed to sell Shares.
	 	 
	17.	VOTING
    RIGHTS
	 	 
	 	Options
    that have not yet been exercised shall not have any voting rights. Following the exercise of Options, the Underlying Shares
    shall have voting rights as specified in this Section below. Each of the Underlying Shares shall entitle the holder thereof
    to one vote at shareholders meetings of the Company. The Trustee shall forward any notice regarding shareholders meetings
    to the last address of the Participants provided to the Trustee by the Company. A Participant, who wishes to exercise his/her
    right to vote at such meeting, shall send a letter to the Trustee at least four (4) working days before the meeting. The Trustee
    shall issue a power of attorney to such Participant, enabling the Participant to vote the number of Underlying Shares held
    for him/her in trust, in accordance with the Company’s Articles of Association. Notwithstanding the above, until consummation
    of the Company’s IPO, Shares issued to a Participant or to the Trustee for the benefit of a Participant, shall be voted
    by an irrevocable proxy assigned to the Company Secretary.

 

CONFIDENTIAL

 

    	 	 17	  

    	 	 	 

    

 

	18.	TAX
    MATTERS
	 	 
	 	This
    Plan shall be governed by, and shall conform with and be interpreted so as to comply with, the requirements of the Ordinance
    and the Code, as applicable and any written approval from any relevant Tax Authorities. All tax consequences under any applicable
    law (other than stamp duty) which may arise from the Grant or Allocation of Options, from the exercise thereof or from the
    holding or sale of Underlying Shares (or other securities issued under the Plan) by or on behalf of the Participant, shall
    be borne solely by the Participant. The Participant shall indemnify the Company and/or Affiliate, as the case may be, and
    hold them harmless, against and from any liability for any such tax or any penalty, interest or indexing.
	 	 
	 	In
    an event of a disqualifying disposition with respect to Options Granted to a Non-Israeli Participant, such Options shall be
    treated in accordance with the requirements of the Code.
	 	 
	 	The
    Fair Market Value of the Shares shall be determined in accordance with Section 7.1 of this Plan, unless required otherwise
    by any applicable Law.
	 	 
	19.	WITHHOLDING
    TAXES
	 	 
	 	Whenever
    an amount with respect to withholding tax relating to Options Granted to a Participant and/or Underlying Shares issued upon
    the exercise thereof is due from the Participant and/or the Company and/or an Affiliate and/or the Trustee, the Company and/or
    an Affiliate and/or the Trustee shall have the right to demand from a Participant such amount sufficient to satisfy any applicable
    withholding tax requirements related thereto, and whenever Shares or any other non-cash assets are to be delivered pursuant
    to the exercise of an Option, or transferred thereafter, the Company and/or an Affiliate and/or the Trustee shall have the
    right to require the Participant to remit to the Company and/or to the Affiliate, or to the Trustee an amount in cash sufficient
    to satisfy any applicable withholding tax requirements related thereto. If such amount is not timely remitted, the Company
    and/or the Affiliate and/or the Trustee shall have the right to withhold or set-off (subject to Law) such Shares or any other
    non-cash assets pending payment by the Participant of such amounts.
	 	 
	 	With
    regard to Options Granted to Israeli Participants - until all taxes have been paid in accordance with Rule 7 of the Section
    102 Rules, Options and/or Underlying Shares may not be sold, transferred, assigned, pledged, encumbered, or otherwise willfully
    hypothecated or disposed of, and no power of attorney or deed of transfer, whether for immediate or future use may be validly
    given. Notwithstanding the foregoing, the Options and/or Underlying Shares may be validly transferred in accordance with Section
    22 below, provided that the transferee thereof shall be subject to the provisions of Section 102 and the Section 102 Rules
    as would have been applicable to the deceased Israeli Participant were he or she to have survived.

 

CONFIDENTIAL

 

    	 	 18	  

    	 	 	 

    

 

	20.	MATERIAL
    BREACH
	 	 
	 	In
    an event of a material breach by a Participant of the terms of this Plan or the Grant Letter provided to him or her, and without
    derogating any of the remedies available to the Company under any applicable law, the Company may, at its sole discretion,
    after sending a written notice to such Participant, forfeit the right of the Participant to some or all the Options Granted
    to such Participant.
	 	 
	21.	NO
    TRANSFER OF OPTIONS
	 	 
	 	The
    Trustee shall not transfer Options to any third party, including a Participant, except in accordance with instructions received
    from the Administrator.
	 	 
	22.	TRANSFER
    OF RIGHTS UPON DEATH
	 	 
	 	No
    transfer of any right to an Option or Underlying Share issued upon the exercise thereof by will or by the laws of descent
    shall be effective to bind the Company unless the Company shall have been furnished with the following signed and notarized
    documents:

 

	 	(A)	A
    written request for such transfer and a copy of the legal documents creating and confirming the right of the person acting
    with respect to the Participant’s estate and of the transferee;
	 	 	 
	 	(B)	A
    written consent by the transferee to pay any amounts in connection with the Options and Underlying Shares any payment due
    according to the provisions of the Plan and otherwise abide by all the terms of the Plan; and
	 	 	 
	 	(C)	any
    such other evidence as the Administrator may deem necessary to establish the right to the transfer of the Option or Underlying
    Share issued upon the exercise thereof and the validity of the transfer.

 

	23.	NO
    RIGHT OF OTHERS TO OPTIONS
	 	 
	 	Subject
    to the provisions of the Plan (including in a case of Death stated in sec 11.3 above), no person other than the Participant
    shall have any right with respect to Options Granted to the Participant’s under the Plan.
	 	 
	24.	EXPENSES
    AND RECEIPTS
	 	 
	 	The
    expenses incurred in connection with the administration and implementation of the Plan (including any applicable stamp duty,
    it any) shall be borne by the Company. Any proceeds received by the Company in connection with the exercise of any Option
    may be used for general corporate purposes.

 

CONFIDENTIAL

 

    	 	 19	  

    	 	 	 

    

 

	25.	REQUIRED
    APPROVALS
	 	 
	 	The
    Plan is subject to the receipt of all approvals required under the Ordinance, the Code and the Law, to the extent required.
	 	 
	26.	APPLICABLE
    LAW
	 	 
	 	This
    Plan and all documents delivered or executed by the Company or Affiliate in connection herewith shall be governed by, and
    construed and administered in accordance with the Law.
	 	 
	27.	TREATMENT
    OF PARTICIPANTS
	 	 
	 	There
    is no obligation for uniformity of treatment of Participants.
	 	 
	28.	NO
    CONFLICTS
	 	 
	 	In
    the event of any conflict between the terms of the Plan and the Grant Letter, the Plan shall prevail, unless the Grant Letter
    stated specifically that the conflicting provision in the Grant Letter shall prevail.
	 	 
	29.	PARTICIPANT
    UNDERTAKINGS
	 	 
	 	By
    entering into this Plan, the Participant shall (1) agree and acknowledge that he or she has received and read the Plan and
    the Grant Letter; (2) undertake all the provisions set forth in: the Code, Section 3i, or Section 102 (including provisions
    regarding the Capital Gains Tax Track) as applicable, the Plan, the Grant Letter and the Trust Agreement (if applicable);
    and (3) if the Options are Granted under Section 102, the Israeli Participant shall undertake that subject to the provisions
    of Section 102 and the Rules, he or she shall not to sell or release the Underlying Shares from trust before the end of the
    Holding Period (if any).
	 	 
	30.	MISCELLANEOUS
	 	 
	30.1.	TERM
    OF THE PLAN
	 	 
	 	The
    Plan shall be in effect until the earlier of: (1) January 30, 2016; or (2) the date it is terminated by the Board of the Company.
	 	 
	30.2.	PARTICIPANT’S
    RANK
	 	 
	 	Nothing
    in this Plan and/or in the Grant Letter shall be construed as granting a Participant any preference above those of a regular
    creditor of the Company with respect to any of liability of the Company in connection to the exercise of the Options, in whole
    or in part, which has not yet been consummated.

 

*
* * *

 

CONFIDENTIAL

 

    	 	 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]